Galmed Pharmaceuticals
GLMD
GLMD
22 hedge funds and large institutions have $1.7M invested in Galmed Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
62% less capital invested
Capital invested by funds: $4.47M → $1.7M (-$2.77M)
Holders
22
Holding in Top 10
–
Calls
$9K
Puts
–
Top Buyers
| 1 | +$38K | |
| 2 | +$32.3K | |
| 3 | +$27.6K | |
| 4 |
Renaissance Technologies
New York
|
+$21K |
| 5 |
Morgan Stanley
New York
|
+$19.7K |
Top Sellers
| 1 | -$412K | |
| 2 | -$318K | |
| 3 | -$29.4K | |
| 4 |
BlackRock
New York
|
-$14K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3K |